Evidence map›Paper›PMID 31284037›Full record

ReviewClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2020

Profiling infectious diseases in Turkey after the influx of 3.5 million Syrian refugees.

Ö Ergönül, N Tülek, I Kayı, H Irmak, O Erdem, M Dara

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Respiratory Emergencies in Disasters: A Narrative Review.Thoracic research and practice · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Impact of Wars and Disasters on Tuberculosis Epidemiology.Journal of clinical practice and research · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ö ErgönülKoç University, School of Medicine, Infectious Diseases Department, Istanbul, Turkey. Electronic address: oergonul@ku.edu.tr.
N TülekAtılım University, Faculty of Medicine, Ankara, Turkey.
I KayıKoç University, School of Medicine, Department of Public Health, Istanbul, Turkey.
H IrmakMinistry of Health, Public Health Institute, Ankara, Turkey.
O ErdemMinistry of Health, Public Health Institute, Ankara, Turkey.
M DaraCommunicable Diseases, WHO Regional Office for Europe, Copenhagen, Denmark.
Koç University · TRMinistry of Health · TRAtilim University · TRWorld Health Organization Regional Office for Europe · DK

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundSince 2011, the conflict in Syria has led to over five million refugees. Turkey hosts the highest number of Syrian refugees in the world. By February 2019 over 3.6 million people had fled to Turkey to seek safety. Only 6.1% of Syrian refugees live in temporary shelters. Owing to the disrupted healthcare services, many children coming from the conflict zones are less likely to have received vaccination. In temporary shelters immunization coverage is >95% and the refugee population is receptive to vaccination.

aimsThe objective of this study was to review the infectious diseases situation among Syrian refugees in Turkey. SOURCES: We have reviewed the reports and studies provided by the governmental and non-governmental organizations and obtained more detailed data from the Ministry of Health in Turkey. CONTENT: Between 2012 and 2016, 1 299 209 cases of respiratory tract infection and 158 058 episodes of diarrhoea with 59 bloody diarrhoeas were reported; 1354 hepatitis A cases and 108 active tuberculosis cases were detected and treated in the temporary shelters for Syrian refugees. Overall in Turkey, 7794 cutaneous leishmaniasis have been reported. IMPLICATIONS: Since the influx of Syrian refugees, there has been an increase in cases of leishmaniasis and measles. No significant increase was detected for tuberculosis, other vector-borne infections, and healthcare associated or sexually transmitted infections. The Syrian refugees can be considered as a vulnerable group in Turkey due to their living and working conditions. Based on available data and our detailed analysis, the numbers show a stable situation regarding infectious diseases.

Indexed as

RefugeesCommunicable Disease ControlCommunicable DiseasesFemaleHumansImmunization ProgramsMalePublic Health SurveillanceSyriaTurkeyVaccination CoverageVaccine-Preventable DiseasesInfectious diseasesRefugeesSyrian refugee influxSyrian refugeesTurkey

Identifiers

PMID31284037
PMCPMC7129060
OpenAlexW2953492617

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.